2 recruiting, 1 unknown. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Recruiting 1, Unknown 1 |
| Phase 1 | 1 | Recruiting 1 |
Follow Resectable Head and Neck Squamous-cell Carcinoma: new trials by email Literature Review of Resectable Head and Neck Squamous-cell Carcinoma trials Research Report on Resectable Head and Neck Squamous-cell Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effects of Infusion Timing on Treatment Response in Solid Tumors PD-1/PD-L1 inhibitor monotherapy - 4 cycles before 12:00PM, PD-1/PD-L1 inhibitor monotherapy - 4 cycles after 3 PM, PD-1 inhibitor monotherapy - 2 cycles before 12:00PM - Lung Cancer, Non-small Cell Lung Cancer | Phase 2 | Recruiting | UNC Lineberger Comprehensive Cancer Center | 238 | 2026-08-03 | 2026-09-15 |
| Decitabine in Combination With Standard of Care Therapy for the Treatment of Surgically Resectable HPV-Negative Head and Neck Cancer Biospecimen Collection, Chemotherapy, Decitabine - Human Papillomavirus-Negative Neck Squamous Cell Carcinoma, Resectable Head and Neck Squamous Cell Carcinoma | Phase 1 | Recruiting | Mayo Clinic | 32 | 2026-01-23 | 2026-07-15 |
| Neoadjuvant Tislelizumab Plus Chemotherapy for Resectable Locally-advanced Head and Neck Squamous Cell Carcinoma Tislelizumab, Nab-paclitaxel, Carboplatin - Head and Neck Squamous Cell Carcinomas, Resectable Head and Neck Squamous-cell Carcinoma | Phase 2 | Unknown | Xiang Lu | 30 | 2023-01-01 | 2024-02-01 |
Carcinoma, Non-Small-Cell Lung (1) · Carcinoma, Squamous Cell (1) · Head and Neck Neoplasms (1) · Lung Neoplasms (1) · Squamous Cell Carcinoma of Head and Neck (1)
Carcinoma (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms by Site (2) · Neoplasms, Glandular and Epithelial (2) · Bronchial Neoplasms (1) · Carcinoma, Bronchogenic (1) · Carcinoma, Squamous Cell (1) · Head and Neck Neoplasms (1) · Lung Diseases (1) · Neoplasms, Squamous Cell (1) · Respiratory Tract Diseases (1) · Respiratory Tract Neoplasms (1) · Thoracic Neoplasms (1)
130-nm albumin-bound paclitaxel (1) · Carboplatin (1) · Congresses as Topic (1) · Decitabine (1) · Drug Therapy (1) · Injections (1) · Radiation (1) · Specimen Handling (1) · Surgical Procedures, Operative (1) · tislelizumab (1)
Mayo Clinic (1) · UNC Lineberger Comprehensive Cancer Center (1) · Xiang Lu (1)
United States (2) · China (1)
Adam L. Holtzman, MD (1) · Guangyuan Hu, professor (1) · Shetal A Patel, MD (1)